Daniel H. Shu

Hematology Oncology | Surgical Oncology

22 South Greene Street
Floor 1
Baltimore, MD 21201

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 18 publications

Publisher Correction: Mutant KRAS vaccine with dual checkpoint blockade in resected pancreatic cancer: a phase I trial.

Publisher Correction: Mutant KRAS vaccine with dual checkpoint blockade in resected pancreatic cancer: a phase I trial.

Journal: Nature communications

Published: April 15, 2026

Correction: Nivolumab and Relatlimab for the Treatment of Patients with Unresectable or Metastatic Mismatch Repair-Proficient Colorectal Cancer.

Correction: Nivolumab and Relatlimab for the Treatment of Patients with Unresectable or Metastatic Mismatch Repair-Proficient Colorectal Cancer.

Journal: Clinical cancer research : an official journal of the American Association for Cancer Research

Published: October 27, 2025

Mutant KRAS vaccine with dual checkpoint blockade in resected pancreatic cancer: a phase I trial.

Mutant KRAS vaccine with dual checkpoint blockade in resected pancreatic cancer: a phase I trial.

Journal: Nature communications

Published: June 25, 2025

Mutant KRAS vaccine with dual checkpoint blockade in resected pancreatic cancer: a phase I trial.

Mutant KRAS vaccine with dual checkpoint blockade in resected pancreatic cancer: a phase I trial.

Journal: Nature communications

Published: June 25, 2025

Neoadjuvant Immunotherapy Promotes the Formation of Mature Tertiary Lymphoid Structures in a Remodeled Pancreatic Tumor Microenvironment.

Neoadjuvant Immunotherapy Promotes the Formation of Mature Tertiary Lymphoid Structures in a Remodeled Pancreatic Tumor Microenvironment.

Journal: Cancer immunology research

Published: April 09, 2025

More than the sum: How vascular endothelial growth factor inhibition unlocks the full potential of immune checkpoint blockade.

More than the sum: How vascular endothelial growth factor inhibition unlocks the full potential of immune checkpoint blockade.

Journal: Immunity

Published: March 07, 2025

DNAJ-PKAc induces metabolic rewiring and enhanced glutamine flux in fibrolamellar HCC.

DNAJ-PKAc induces metabolic rewiring and enhanced glutamine flux in fibrolamellar HCC.

Journal: Journal of hepatology

Published: February 17, 2025

Nivolumab and Relatlimab for the Treatment of Patients with Unresectable or Metastatic Mismatch Repair-Proficient Colorectal Cancer.

Nivolumab and Relatlimab for the Treatment of Patients with Unresectable or Metastatic Mismatch Repair-Proficient Colorectal Cancer.

Journal: Clinical cancer research : an official journal of the American Association for Cancer Research

Published: January 03, 2025

Maturation of Tertiary Lymphoid Structures.

Maturation of Tertiary Lymphoid Structures.

Journal: Methods in molecular biology (Clifton, N.J.)

Published: November 11, 2024

Spatial multi-omics reveal intratumoral humoral immunity niches associated with tertiary lymphoid structures in pancreatic cancer immunotherapy pathologic responders.

Spatial multi-omics reveal intratumoral humoral immunity niches associated with tertiary lymphoid structures in pancreatic cancer immunotherapy pathologic responders.

Journal: bioRxiv : the preprint server for biology

Published: October 10, 2024

Deep immune profiling of intrahepatic cholangiocarcinoma with CODEX multiplexed imaging.

Deep immune profiling of intrahepatic cholangiocarcinoma with CODEX multiplexed imaging.

Journal: Hepatology communications

Published: July 17, 2024

Age-related divergence of circulating immune responses in patients with solid tumors treated with immune checkpoint inhibitors.

Age-related divergence of circulating immune responses in patients with solid tumors treated with immune checkpoint inhibitors.

Journal: Nature communications

Published: May 14, 2024

Showing 1-12 of 18

Last Updated: 09/26/2026